Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent (Q37055215)

18 August 2017

1 reference

title

Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent (English)

1 reference

18 August 2017

Vijayalakshmi Nagappan

series ordinal

1

1 reference

PubMed ID

18190324

18 August 2017

Stan Deresinski

series ordinal

2

1 reference

PubMed ID

18190324

18 August 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

Clinical Infectious Diseases

18 August 2017

1 reference

18 August 2017

45

1 reference

18 August 2017

12

1 reference

18 August 2017

1610-1617

1 reference

High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation

18 August 2017

1 reference

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

Invasive mold infections in allogeneic bone marrow transplant recipients.

21 January 2018

1 reference

The new fungal opportunists are coming

21 January 2018

1 reference

Second-generation azole antifungal agents

21 January 2018

1 reference

Voriconazole: a new triazole antifungal agent

21 January 2018

1 reference

Anidulafungin: a novel echinocandin

21 January 2018

1 reference

Posaconazole: a broad-spectrum triazole antifungal

21 January 2018

1 reference

Zygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole?

21 January 2018

1 reference

Treatment of Scedosporium apiospermum brain abscesses with posaconazole

21 January 2018

1 reference

Activity of posaconazole in the treatment of central nervous system fungal infections

21 January 2018

1 reference

Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding.

21 January 2018

1 reference

Posaconazole is a potent inhibitor of sterol 14alpha-demethylation in yeasts and molds

21 January 2018

1 reference

Mechanism of azole antifungal activity as determined by liquid chromatographic/mass spectrometric monitoring of ergosterol biosynthesis

21 January 2018

1 reference

Pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy men

21 January 2018

1 reference

Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults

21 January 2018

1 reference

Oral bioavailability of posaconazole in fasted healthy subjects: comparison between three regimens and basis for clinical dosage recommendations

21 January 2018

1 reference

Posaconazole plasma concentrations in juvenile patients with invasive fungal infection

21 January 2018

1 reference

Effect of a nutritional supplement on posaconazole pharmacokinetics following oral administration to healthy volunteers

21 January 2018

1 reference

Human pharmacogenomic variations and their implications for antifungal efficacy

21 January 2018

1 reference

Disposition of posaconazole following single-dose oral administration in healthy subjects

21 January 2018

1 reference

Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration

21 January 2018

1 reference

Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study

21 January 2018

1 reference

Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults

21 January 2018

1 reference

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

21 January 2018

1 reference

Posaconazole pharmacokinetics, safety, and tolerability in subjects with varying degrees of chronic renal disease

21 January 2018

1 reference

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

21 January 2018

1 reference

Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection

21 January 2018

1 reference

Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis

21 January 2018

1 reference

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

21 January 2018

1 reference

In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts

21 January 2018

1 reference

Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.

21 January 2018

1 reference

Risk of Fungemia Due to Rhodotorula and Antifungal Susceptibility Testing of Rhodotorula Isolates

21 January 2018

1 reference

Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi

21 January 2018

1 reference

In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates

21 January 2018

1 reference

In vitro activities of four novel triazoles against Scedosporium spp

21 January 2018

1 reference

In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes

21 January 2018

1 reference

In vitro susceptibilities of zygomycetes to conventional and new antifungals

21 January 2018

1 reference

In vitro activity of posaconazole against clinical isolates of dermatophytes

21 January 2018

1 reference

Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections

21 January 2018

1 reference

In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model

21 January 2018

1 reference

SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum ("Ramichloridium mackenziei")

21 January 2018

1 reference

Antifungal therapy of experimental cerebral phaeohyphomycosis due to Cladophialophora bantiana

21 January 2018

1 reference

Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice

21 January 2018

1 reference

In vitro and in vivo activities of posaconazole against Coccidioides immitis

21 January 2018

1 reference

Interaction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivo

21 January 2018

1 reference

Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases

21 January 2018

1 reference

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

21 January 2018

1 reference

Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex

21 January 2018

1 reference

Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipient

21 January 2018

1 reference

Posaconazole as Salvage Treatment for Invasive Fusariosis in Patients with Underlying Hematologic Malignancy and Other Conditions

21 January 2018

1 reference

Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera

21 January 2018

1 reference

Refractory coccidioidomycosis treated with posaconazole

21 January 2018

1 reference

Posaconazole therapy for chronic refractory coccidioidomycosis

21 January 2018

1 reference

Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection

21 January 2018

1 reference

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/523576

1 reference

18 August 2017

1 reference

PubMed ID

18190324